RBVRR WOMEN'S COLLEGE OF PHARMACY

3-4-343, Barkathpura, Hyderabad - 500027, Ph: 040-27563065

Pharmaceutical Chemistry

Pharmaceutical Chemistry

PHARMACY PHARMACEUTICAL CHEMISTRY PROJECT TITLES 2010 – 2012
R.No. Name of the Student Title of the Books
1-001 S.P.Anupama Synthesis and Docking studies of novel series of Pyridazine (.1-c) (1,2,4) Triazines
2-002 Lateef Unnisa Development of Industrial Proces for N-Methyl Pyridine -2- Aldoxime Salts of Pharmaceutical Importance
3- 003 P.Megha A Novel Synthesis, Characterization And Docking Studies of 2-Thio-Substituted Benzo(d) Thiazole Derivatives
4-004 K.Rama A Project Report on “Synthesis, Characterisation and Docking studies of some novel series of 7-(O-Triazolo pyridazin -3yl)-4- methyl coumarins”.
 5-005 N.Mounika Synthesis, Characterization and Docking Studies of Novel Series of 2-Substitued – 6- arylpyridazin-3(2H)- Ones as Dopaminergic agents.
6-006 A.Sravya Synthesis and Docking Studies of Novel 2- Substituted -6- Arylpyridazine -3(2H)-Ones as 5HT2A Antagonists.
7-007 M.Sukanya Synthesis, Characterisation and Anti Bacterial Activity of Mannich Bases of Coumarins.
8-008 N.S.P. Sirisha Synthesis, Docking Studies and invitro CytotoxicEvaluation of Novel 4—(benzo(d) thiazol-2-yl)-N-Phenylaniline derivatives.
 9-009 P.Spoorthi Synthesis and Docking Studies of 3,7- Disubstituted-Pyridazin(8,1-c) (1,2,4) Triazines As Novel PDE-4 Inhibitors.
10-010 T.Vinayalaxmi Synthesis, Characterization and Docking Studies of Novel 6-Aryl 2- (Piperidin-1-yl/pyrrolidin-1-yl) Bensothiazole Derivatives.
11-011 P.Saritha Synthesis, Charcterization and Docking Studies of Novel Series of 2-(5(1H)- Tetrazolo)-YL-6-ARYL-4,5-Dihydro/Dehydro-Pyridazin-3(2H)-Ones.
12-012 P.V.Nageswari Synthesis, Characterization and Biological Evaluation of a Series of Schiff’s Bases of 2-(2-OXO-ARYL) Ehyl Pyridazin=3-Thiones.
13-013 K.Suneetha Synthesis, Characterization and Biological Ebaluation of Novel 1,2,3-TRI-Substituted Indoles.
14-014 Poonam Chakravarthy Homology Moderling and Validation of Human FGFR4-Tyrosine Kinase domain using Structure based Studies.
15-015 K.Rajitha Molecular Docking and Virtual Screening for Novel inhibitors of Protein tyrosine phosphates 1B (PTP1B).
16-016 K.Sailaja In-Silico Screening of Inhibitors for the Human Siah 2, Implications for Hypoxia- Induced Cancers.
2011 – 2013
R.No. Name of the Student Title of the Books
1-001 K.Geetha Reddy Synthesis, Characterization, Docking Studies and Biological Evaluation of Some Novel 2,4,5,6 Tetra Substituted Pyridazin =3(2H) Ones.
2-002 K.P.Sunitha Optimization, Characterization of Imputly Profile of Telmisartan By Improved Synthetic Activity of Impurity (Chloro Analog).
3-003 V. Tejaswini Synthesis, Characterization, Docking Studies And Biological Ebaluation of Some Novel Mannich Bases of Pyridazin-3(2H)-Thione Derivatives.
4-004 N.Swetha Synthesis, Characterization, Docking Studies And Biological Evaluation of Some Novel Pyrimido (4,5-c) Pyridazines.
5-005 D. Sai Sudha Synthesis, Characterization and Docking Studies and Novel Seies of Pyridazinone Substituted Benzene Sulfonylureas.
6-006 S.Srujana Synthesis, Characterization, Docking Studies and Biological Evaluation of Some Novel Sulfamoyl Phenyl Peridazinone.
7-007 R.Sumala Synthesis, Charcterization and In-Silico Evaluation of Novel Phthalazine Derivatives as Antihypertensive Agents.
8-008 P.Spandana Synthesis, Characterization, Docking Studies And Biological Ebaluation of Some Novel 4-Pyrazolyl Substituted  Pyridazin -3(2H)- Ones.
2012 – 2014
R.No. Name of the Student Title of the Books
1-001 Priyanka Reddy. Vangala Insilico Screening of Novel HSP90 Inhibitors Based on Imidiaso Pyrimidines / Bensimidazoles Substituted Derivatives by 3DQSAR And Docking.
2-002 Preethi. B Homology Modeling of Stat3 Protein And Virtual Screening of Stat3 Inhibitors Based on Tetrazole / Quinazolin/ Thiophene Substituted Amides by Docking And 3DQSAR Studies.
3- 004 Amreen Begum 3DQSAR, Docking And Adme Studies of Novel 1,2 Bensisothiazol 3(2H)-One, Oxidiazole & Other Hybrid Derivatives As Potent Inhibitors of Dengue Virus NS2B/NS3.
4-005 Mounika , Morampudi Virtual Screening of JAK2 Inhibitors Based on Pyrrolotriazines/ Triazolopyridines by 3DQSAR And Docking.
 5-006 Sri Vidya , Chitukula Homology Modeling of Transient Receptor Potential Vanilliod, (TRPV1) And Insilico Screening of Novel TRPV1 Inhibitors Based on Diarylpentadienamide Derivatives By 3D-QSAR And Docking Studies.
6-007 Haritha, Somavar In Silico Screening of H-Imidazo(4,5-B) PYRIDIN-2(3H)- Onederivatives As Novel Inhibitors of B Rafkinase By 3DQSAR And Docking Studies.
7-009 Vamshi Priya, N Virtual Screening of Novel Rho Kinase Inhibitors Based on Pyrazole Substituted Benzamides / Quinazolines And Other Amides By 3D QSAR And Docking Studies.
8-010 Madeni Ayesha In Silico Screening of Novel Inhibitors of 5-LOX Based On Naphthyl Prinixic Acid/Indole Derivatives By 3D QSAR And Docking Studies.
 9-011 Mounika, Are Molecular Modeling of Indolinone Derivatives As Transforming Growth Factor Beta Receptori (TGFBR1) Inhibitors By 3D QSAR And Docking Studies Based On fused Nitrogen Containing Heterocycles.
 2013 – 2015
   R.No. Name of the Student Title of the Books
1-001 2013-15 M.Kavitha Roll.No.170613884001 Isolation, Characterization of phytochemical constituents and pharmacological investigation of Cissus vitiginea leaves.
2014- 2016
R.No. Name of the Student Title of the Books
1-012 S. Namitha Molecular docking Pharmacophore Mapping and admet studies of Benzimidazole derivatives as inhi- bitors of Human Cyclin Dependent Kinase 2 enzyme.
2016-2018 
R.No. Name of the Student Project Titles
1-001 Sadiya Fatima Roll. No:1706-16-884-001 synthesis, characterization and biological evaluation of 2-hydroxy-2-methyl-6-arys-2-3-dihyro-7h-[1,3] thiazolo [3,2-b] [pyridazine.
2-004 Haleema Zainab Begum Roll. No:1706-16-884-004 Synthesis, Characterization, Biological activity of Some Novel Mannich Bases of Pyridazine -3(2H)- Ones Derivatives.
2017-2019 
R.No. Name of the Student Project Titles
1-001 A. Monalika Roll. No:1706-17-884-001 Design Molecular Docking Synthesis And Biological Evaluation of Novel 2,5-Substituted Imidazole Derivatives As Anti-Inflammatory Agents.
2-002 Akula Akhila Sai Roll. No:1706-17-884-002 Design Molecular Docking Synthesis Biological Evaluation of 4,5-Substituted 1,2,3-Triazoles As Antibacterial Agents.
3-003 Ayesha Begum Roll.No:1706-17-884-003 Isolation And Characterization of Phytochemicals From Leaves of Cissus Pallida.
4-004 B. Naga Jyothi Roll.No:1706-17-884-004 Synthesis Molecular Docking And Anti-Diabetic Evaluation of Some New Sulphonamido Substituted Imidazolone Derivatives.
5-005   P. Shravani Roll.No:1706-17-884-005 Synthesis Molecular Docking, and Anti Bacterial Activity of Some New 3-Sulphonamido Substituted Quinazolinone Derivatives.
 2016-2019
R.No. Name of the Student Project Titles
1-002 Jadi Amani Rani Roll. No:1706-16-884-002 Synthesis, Characterization And Biological Evaluation Series of Schiffs Bases of 2-(2-OXO-2-Methyl)-Propyl 6-Aryl- 4,5-Dihydro Pyridazine-3-Thiones.
2018-2020
S.No. Name of the Student Project Titles
4002 Syeda Advia Sanobar Structure Based Virtual Screening, Design, Synthesis, And Biological Evaluation Of 3-Sulfonamido Substituted Quinazolinones As Anti- Zika Viral Agents
4004 Zaberunnisa Synthesis, Characterization, Molecular Docking And Biological Evaluation Of N-(Benzyloxy)-1h-Indole-2- Carboxamide Derivatives
4005 K. Sreelatha Structure Based Virtual Screening, Design, Synthesis And Biological Evaluation Of Imidazoles As Antidiabetic Agents
4006 Nagma Begum Synthesis, Characterization, Molecular Docking And Biological Evaluation Of 6-Methoxy-Benzothiazol-2-Yl-Amide Derivatives
 2019-2021
   S.No. Name of the Student Title of the Books
1-001 Guide: Meher Unnisa Roll.No.170619884001 Dr.K.Sruthi Insilico Approaches for the Design and Synthesis of N-Substituted Imidazolyl Amido Coumarin Derivatives as new dual mPGES-1/5-Lo Inhibitors.
2-002 Guide: M.Maneesha Roll.No.170619884002 Dr.K.Sruthi Insilico Approaches for the design and synthesis of potent istatin sulfonamide as alphaglucosidase inhibitors implicated in treatment of diabetes.
3- 003 2018-21 Guide: Nagaram Pranaya Roll.No.170618884003 Dr.M.Vijaya Bhargavi Structure based virtual screening , design, synthesis, biological evaluation of indole derivatives as respiratory syncytial virusfusion (RSV-F) inhibitors.
 2020—2022
   S.No. Name of the Student Title of the Books
1-001 Guide: Palmoni Manisha Roll.No.170620884001 Dr.M.VijayaBhargavi QSAR-Based Virtual screening, Molecular Docking , Synthesis, and Biological Evaluation of Coumarin ad 1,3,4-Oxadiazole Hybrids as Anticancer Agents.
2-002 Guide: Thoka Shirisha Roll.No.170618884001 Dr.M.VijayaBhargavi (2018- 2021) Structure Based Virtual Screening, Design, Synthesis and Biological Evaluation of Coumarin-Benzothiazole Hybrid Derivatives as INHA ( Enoyl acyl carrier protein reductase) Inhibitors in the Treatment of Tuberculosis.
 2021—2023
   S.No. Name of the Student Title of the Books
1-001 Guide: Mameena Sahoo Roll.No.170621884001 Dr.M.VijayaBhargavi Structure Based Virtual Screening, Molecular Docking, Syntheses and Biological Evaluation of Benzothiazole and 1,2,4- Oxadiazole Hybrids as oral antidiabetic agents
2-002 Guide: Shafia Sultana Roll.No.170621884002 Dr..M.VijayaBhargavi Qsar Based virtual screening, Molecular Docking, Sythesis and Biological evaluation olf Indole and Quinazolinone hybrid derivatives as P13K inhibitors for the treatment of cances.
3-003 Guide: Shahista Begum Roll.No.170621884003 Dr..M.VijayaBhargavi Structure – based virtual screening, molecular docking, synthesis and biological evaluation of 1,3,4- oxadiazole and 1,2,4- Triazole derivaties as antibacterial agents.
2016-2020 B.Pharmacy (CBCS) Mini Project Titles
  S.No.     Roll no. Name of the Student & Guide   Project Title
1 31 K. Mounika Dr. M. Vijaya Bhargavi Synthesis, characterisation of 7-Substituted-4-Methyl coumarin derivatives as anti-inflammatory agents.
2 84 S. Vagdevi Dr. M. Vijaya Bhargavi Ligand based virtual screening of coumarin derivatives as NHE (Na+/H+ exchange) inhibitors for the treatment of cancer
3 80, 77 Syeda rabab Fatima & k. Sushma Dr. K. Sruthi Mechanochemical synthesis of novel-4-arylidine oxazolone derivatives
4 83 Usha Shalini Dr. K. Sruthi Ligand based virtual screening of pyrimidine derivatives in the treatment of NIPAH virus infections
5 59 Sai bhavani Mrs. V. Padmaja Design and virtual screening of pyrimidine derivatives as potent anticancer agents.
6 28 G. Manasa Mrs.S.P.Anupama Design and virtual screening of novel inhibitors of NS2B-NS3 protease in the treatment of Dengue viral infections
7 16 V. Chandrika Mrs. P. Archana Design and virtual screening of Quinoline derivatives as InhA (enoyl acyl carrier protein reductase) inhibitors for the treatment of tuberculosis
8 87 Vindyasree Mrs. Padma Bhavani Design and virtual screening of beta carboline derivatives as potent anticancer agents
  B PHARMACY PROJECTS (2017-21)
  S.No.     Roll no. Name of the Student & Guide   Project Title
1 170617881054 170617881056 170617881057 170617881099 170617881100   LokaShivani Manchella Sai Supriya MangaliMamatha SukkaDivija VarriNishitha Dr. M. Vijaya Bhargavi Virtual screening, molecular docking and drug likeliness prediction of Pyramidine containing heterocyles as JAK 2 inhibitors for the treatment of RA
2 170617881048 170617881020 170617881002 170617881004 170617881024 Kavya Reddy Chavidi Sreejani A.Sripriya Agalduty Neha Dharmula Samatha Dr. K. Sruthi Active site prediction, Virtual screening and molecular docking studies for ligands of some orphan receptors
B PHARMACY PROJECTS (2018-22)
  S.No.     Roll no. Name of the Student & Guide   Project Title
1 170618881052 170618881062 170618881064 170618881080 170618881099 D.Preethi Laya K.Rithika T.Sai sankeerthana C.Srija K.Supriya   Dr. M. Vijaya Bhargavi Structure based virtual screening, molecular docking of Coumarin derivatives as BACE I inhibitors for the treatment of Alzheimers disease.  
2 170618881059 170618881061 170618881073 170618881076 170618881078 D.Rani V.Ravali D.V.Shruthi N.Spandana K.Sravanthi Dr. K. Sruthi Insilico studies of various plant derived bioactive compounds as SARS COV2 Protease Inhibitors.
B PHARMACY PROJECTS (2019-23)
  S.No.     Roll no. Name of the Student & Guide   Project Title
1 170619881045 170619881069 170619881073 170619881074 170619881085 M.Raghavi Ria Singh Shaik samreen Sheri Meghana T.Gowthami Prof.M.Sumakanth Design and development of 3D QSAR model for Antidepressants
2 170619881044 170619881046 170619881058 170619881064 170619881065 M.Harshita Singh M.Samyuktha N.Spandana P.Pooja P.Anusha Dr. M. Vijaya Bhargavi Design and development of 3D QSAR model for Anti- Hyperlipedemics
3 170619881015 170619881049 170619881053 170619881057 170619881062 B.Sriharshini M.Laxmi priya M.Srividya N. Sirisha P.Sriharsha Design and development of 3D QSAR model for NSAIDS
Publications
  1. Anti Cancer Activity of Naturally Occurring Heterocyclic Compounds,Shafia Sultana,Pilli Archana, Dr. M. Vijaya Bhargavi,  International Journal of Science and Research (IJSR)Volume 12 Issue 4, April 2023, 195-200.
  2. NOVEL THERAPIES FOR THE TREATMENT OF BREAST CANCER, Shahista Begum, Mameena Sahoo, Dr. M. Vijaya Bhargavi, Prof. Mogili.Sumakanth, Journal of Emerging Technologies and Innovative Research, April 2023, Volume 10, Issue 4, 244-255.
  3. THIAZOLIDINEDIONE AND NON-THIAZOLIDINEDIONES AS PPAR GAMMA AGONISTS, Mameena sahoo, Shahista Begum, Dr. M. Vijaya Bhargavi, Prof. M. Sumakanth, International Journal of Research and Analytical Reviews, April 2023, Volume 10, Issue 2, 483-492.
  4. Newer approaches on rDNA technology in vaccine development, International Journal of Novel Research and Development, Keerthana g , Dr M Vijay bhargavi, Volume 8, issue 12 December
  5. HDAC Inhibitors in Cancer Therapy: Harnessing Epigenetic Modifications in Targeted Treatment, Chencharam Tulasi , Dr. M. Vijaya Bhargavi, International Journal of All Research Education and Scientific Methods, ISSN: 2455-6211, Volume 11, Issue 12, December-2023.
  6. Soluble Guanylate Cyclase Stimulators in Heart Failure, Nida Mirza, Dr. M. Vijaya Bhargavi, International Journal of Science and Research, ISSN: 2319-7064, SJIF (2022): 7.942, Volume 12 Issue 12, December 2023.
  7. Newer approaches on rDNA technology in vaccine development, International Journal of Novel Research and Development, Keerthana g , Dr M Vijay bhargavi, Volume 8, issue 12 December 2023.
  8. Novel Therapies For The Treatment of Breast Cancer, Mogili.Sumakanth Shahista Begum, Mameena Sahoo, Dr. M. Vijaya Bhargavi, April 2023, Journal of Emerging Technologies and Innovative Research (JETIR), Volume10, Issue 4, 244-255. (7.95)
  9. Thiazolidinedione And Non Thiazolidinedione As PPAR Gamma Agonists, M. Sumakanth, Mameena sahoo , Shahista Begum , Dr. M. Vijaya Bhargavi, April 2023, International Journal of Research and Analytical Reviews (IJRAR), Volume 10, Issue 2, 483-492. (7.17)
  10. Anti Cancer Activity of Naturally Occurring Heterocyclic Compounds, Dr. M. Vijaya Bhargavi Shafia Sultana , Pilli Archana, April 2023, International Journal of Science and Research, Volume 12, Issue 4, 195-200. (7.5 impact factor)
  11. Role of Fat Metabolism in Gastric Cancer, A.Shafia Sultana B, Dr. M. Vijaya Bhargavi, C. Prof. M. Sumakanth October 2022, IJIRT, Volume 9 Issue 5, 605-610. (CIF – 4.36)
  12. Structure-Based Virtual Screening, Design,Synthesis And Biological Evaluation of Indole Derivatives as Respiratory Syncytial Virus Fusion (RSV-F) Inhibitors, M.vijaya bhargavi and Dr. M. Sumakanth Polamoni Manisha, Nagaram Pranaya, World Journal of Pharmaceutical Research December 2022, Volume 11, Issue 17, 809-824. (ICV-90.8)
  13. Structure-Based Virtual Screening, Design,Synthesis And Biological Evaluation Of Coumarin-Benzothiazole Hybrid Derivatives as Inha (Enoyl Acyl Carrier Protein Reductase) Inhibitors in The Treatment Of Tuberculosis. Polamoni Manisha, Thota Shirsha, Dr. M.Vijaya Bhargavi, Dr. M Sumakanth, International Journal for Research Trends and Innovation, 2022, IJRTI | Volume 7, Issue 9 | 2456-331
  14. Phase Transfer Catalysts, Polamoni Manisha , Dr. M Vijaya bhargavi, Journal of Emerging Technologies and Innovative Research 9 (4), 515-527, 2022
  15. HYPERTROPHIC CARDIOMYOPATHY, M. VijayaBhargavi, P. Soni Dixitha, International Journal of Pharmaceutical Sciences and Research 13 (8), 3043-3055, 2022.
  16. Design, Molecular Docking, Synthesis and Biological Evaluation of 4, 5-Substituted 1, 2, 3-Triazoles as Anti-bacterial Agents MSZU M. Vijayabhargavi, M. P. Kusuma, Akhila Sai, International Journal of Pharmaceutical Sciences and Nanotechnology, vol 14, Issue 2, 5372-5385, 2021. (0.5, scopus)
  17. A review article of SGLT2 inhibitors for the treatment of diabetes and obesity, PDMS P. Soni Dixitha, Dr.M. Vijaya Bhargavi, Journal of Pharmaceutical Sciences and Research 13 (11), 640-648, 2021. (Scimago Journal)
  18. “Synthesis, Characterization, Molecular Docking and Biological Evaluation of N- (Benzyloxy)-1H-Indole-2-Carboxamide Derivatives” zaber Unnisa, M. Vijaya bhargavi, M.Sumakanth, International Journal of All Research Education and Scientific Methods, 2020, vol 8, issue12, 661-686. (7.429)
  19. Synthesis, Characterization, Molecular Docking and Biological Evaluation of 6- Methoxy-Benzothiazol-2-Yl-Amide Derivatives, Vijaya bhargavi, Nagma begum, M.Sumakanth, 8-11-2020, INTERNATIONAL JOURNAL OF INNOVATIVE RESEARCH IN TECHNOLOGY, vol 7, issue6, 111-122. (sjif 7.37),
  20. A REVIEW ON BIOSIMILARS , Nagma Begum and Dr. M. Sumakanth Zaberunnisa, Dr. M. Vijaya Bhargavi, 2020, European Journal of Biomedical and Pharmaceutical Sciences, vol 7, issue 5, 669-678. (6.04)
  21. “Recent advances in antibiotic hybrids” zaber Unnisa, M. Vijaya bhargavi, Nagma begum, M.Sumakanth, International Journal of Pharmaceutical Sciences and Nanotechnology, 2020, vol13, issue3.(0.5, scopus)
  22. “Design, Molecular Docking, Synthesis And Biological Evaluation Of Novel 2,5-Substituted Imidazole Derivatives As Anti-Inflammatory Agents” Akepogu Monalika and M Vijaya Bhargavi, International Journal of Pharma and Bio Sciences, 2020; doi 10.22376/ijpbs.2020.11.1.p13-27. (Elsevier, 0.8)
  23. A New strategy for bacterial Resistance-Efflux Pump inhibitors” Nagma Begum, M. Vijaya   bhargavi, M.Sumakanth, International Journal of Emerging Technologies and Innovative Research Vol.6, Issue 6, Page no. 477-491, June 2019.
  24. Synthesis, Molecular Docking, Analgesic, and Anti-Inflammatory Activities of New 1,2,4- Oxadiazolo-Sulfonamides Vijaya Bhargavi, P. Shashikala,  M. Sumakanth, C. Krishna, 2018.   RussianJournal of General Chemistry, 88(4), pp 804-811. ( Impact factor – 0.553).
  25. Synthesis, Molecular Docking and Biological Evaluation of Novel N-(Benzyloxy)-6- Fluro- Chromone-2-Carboxamides and N-(Benzyloxy)-Chromone-3-Carboxamides as Analgesic and Anti-inflammatory Agents, Der Pharmachemica, M VijayaBhargavi ,P Shashikala, MSumakanth and J Archana, 2018, 10        (5) ( Impact factor  – 0.4).
  26. Design, Synthesis, and Cytotoxicity of Semisynthetic Betulinic Acid-1,  2, 4-Oxadiazole Amide Derivatives. Krishna, C., Bhargavi, M.V. and Krupadanam, G.L.D., 2018. Russian Journal of General Chemistry, 88(2), pp.312-318.( Impact factor – 0.553).
  27. Design, Synthesis, Molecular Docking and Biological Evaluation of Novel Coumarin-oxime  Ether   Derivatives as COX-2 Inhibitors, 2017, M. Vijaya Bhargavi,P. Shashikala, M.Sumakanth, Shravan        Kumar. Gunda, Asian journal of chemistry, vol 29, No.11, 2559-2564.  ( Impact factor – 0.15).
    1. Coumarins and Chromones : A Remarkable Scaffolds for Anti-inflammatory Activity, 2017, Vijaya Bhargavi M, Shashikala P, Sumakanth M,  Pharm. Sci. & Res. Vol. 9(9), 1483-1489.( Impact factor – 0.59).
    2. Facile Regioselective Synthesis and Antimicrobial Activity of Novel 8-Isoxazolinyl   Coumarins via Nitrile Oxide Cycloaddition Approach Challa Krishna, Vijaya Bhargavi and G.L.     David Krupadanam, 2017, Asian Journal of organic & medicinal chemistry, 2(4),  pp.149-155.
    3. Synthesis of pyranoisoxazoline/isoxazole annulated coumarins via intramolecular nitrile oxide   cycloaddition and their  Krishna, C., Bhargavi, M.V., Rao, Y.J. andKrupadanam,   G.L.D., 2017. Russian Journal of General Chemistry, 87(8), pp.1857-1863.( Impact factor – 0.553).
    4. Design, synthesis and antimicrobial activity of benzyl hydroxamic acid analogues of coumarin Challa Krishna, M Vijaya Bhargavi, G L David Krupadanam,Heterocyclic Letters Vol. 7| No.3|671-     682|May-July| 2017.( SJIF impact factor =3.833).
    5. A Comparative study of Myrosinase Activity in selected Cruciferous Vegetables after Conventional Heat and Microwave Treatments, International Journal of Current Research, Kusuma,       P., Archana Jorige and Vijaya Bhargavi, M.8, (12), 43668-43670, 2016.( Impact factor – 0.553).
    6. Design, semisynthesis and cytotoxic activity of novel ester derivatives of betulinic acid-1,2,4-oxadiazoles.    Journal of Asian Natural Products Research, Volume 18, 2016. Krishna Challa, M   Vijaya Bhargavi, & G L David Krupadanam, pages 1158-1168, 17 Jun 2016. (Impact factor – 0.66).
    7. Synthesis and antimicrobial assessment of novel coumarins featuring 1,2,4-oxadiazole Challa Krishna, Vijaya Bhargavi,Ch.Prasad Rao, G.L. David Krupadanam, Medicinal Chemistry   Research 24(10), October 2015, 3743–3751 (Impact factor – 1.23).
    8. Multidrug resistance in Tuberculosis: An overview by Vijayabhargavi in International Journal of Pharmaceutical and Phytopharmacological Research 2014; 4(3): 157-163.(Indexed in         Thomson Reuters – Web of Science, Elsevier (SCOPUS) ).
    9. Studies on production, purification, and molecular characterization of polygalacturonase from   Bacillus subtilis by M.P.Kusuma and Vijaya Bhargavi in European Journal of Biotechnology and Bioscience 2014; 1(5): 1-6.
    10. Retinoids: An overview of clinical applications in Dermatology by Archana J and Vijaya M, Journal of Pharmaceutical Sciences and Research, Vol.2 (7), 2010, 376-383 ( Impact factor – 0.59).
    11. REVIEW OF ANTICANCER ACTIVITY OF DIHYDROPYRIMIDINONES ,PILLI ARCHANA, TARANNUM FATHIMA,Pharmaceutical Chemistry. International Journal of Creative Research Thoughts.Volume 11, Issue 7 July 2023 | ISSN: 2320-2882.
    12. Anti Cancer Activity of Naturally Occurring Heterocyclic Compounds, Shafia Sultana,Pilli Archana, Dr. M. Vijaya Bhargavi, International Journal of Science and Research (IJSR)Volume 12 Issue 4, April 2023, 195-200.
    13. Bilosomes: Superior vascular carrier to enhance oral and transdermal drug delivery of poorly soluble active drug molecules, M.* And Pilli Archana, European Journal of Pharmaceutical and medical Research, 2024, 11(3), 385-394.
    14. Padmaja V, M. Sumakanth, P.Shashikala (2022)Synthesis, Characterization, Molecular Docking and Biological studies on Novel Pyrazole fused Indole Derivatives.Journal of Pharmaceutical Negative Results,13(5):745-754
    15. V.Padmaja, M. Sumakanth, P.Shashikala (2023) Synthesis, Characterization and Molecular Docking Studies of Novel Mannich Bases of Indole Analogs as Potent Antibacterial and Anticancer Agents.Asian Journal of Chemistry; Vol. 35, No. 1 (2023), 217-223
    16. Padmaja V, M. Sumakanth, P.Shashikala(2023) Synthesis, Characterization, Molecular docking studies of 5substituted-3-(2-methoxy dibenzo[b,d]furan-3-ylimino)-1substituted-indolin-2-ones as potent antimicrobial and anticancer agents. Eur. Chem. Bull. 2023,12(4), 217-234
    17. REVIEW OF ANTICANCER ACTIVITY OF DIHYDROPYRIMIDINONES ,PILLI ARCHANA, TARANNUM FATHIMA,Pharmaceutical Chemistry. International Journal of Creative Research Thoughts.Volume 11, Issue 7 July 2023 | ISSN: 2320-2882.
    18. Anti Cancer Activity of Naturally Occurring Heterocyclic Compounds, Shafia Sultana,Pilli Archana, Dr. M. Vijaya Bhargavi, International Journal of Science and Research (IJSR)Volume 12 Issue 4, April 2023, 195-200.
    19. Bilosomes: Superior vascular carrier to enhance oral and transdermal drug delivery of poorly soluble active drug molecules,  M.* And Pilli Archana, European Journal of Pharmaceutical and medical Research, 2024, 11(3), 385-394